Karthikeyan Arcot
Vascular Neurology · Brooklyn, NYNPI 1205194941
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Penumbra, Inc. at 27.6% of the total. Reporting peaked in 2022 at $956 and has fallen 66.5% since, to $320 in 2025.
Across 77 payments — averaging $49.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$1K
- Medtronic$529
- Stryker$514
- Johnson & Johnson$336
- Imperative Care, Inc$289
- Qapel Medical Inc$272
- plus $822 from 7 others
What the payments were for
- Food & beverage$3,816100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 20 | $1,054 |
| Medtronic(2 entities) | 19 | $529 |
| Stryker | 10 | $514 |
| Johnson & Johnson | 4 | $336 |
| Imperative Care, Inc | 6 | $289 |
| Qapel Medical Inc | 4 | $272 |
| Phenox Inc. | 2 | $200 |
| Microvention, Inc. | 3 | $194 |
| Balt USA, LLC | 1 | $173 |
| Rapid Medical Ltd | 1 | $122 |
| Cardiva Medical, Inc. | 4 | $58 |
| AbbVie | 2 | $46 |
| Genentech USA, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$478
- Avenir Coils$146
- RED 72$146
- WEB$143
- LVIS$143
- Headway Duo Microcatheter$143
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$122
- COMANECI 17$122
- Pipeline$121
- EMBOTRAP II Revascularization Device$117
- Solitaire$106
- TREVO$105
- Benchmark$101
How this compares
$3,816 in reported general payments places this provider in the 80th percentile of 74 vascular neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 29 | $215 |
| Atorvastatin Calcium | 31 | $190 |
| Amlodipine Besylate | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Brooklyn
- Brent FlustyBrooklyn$4K
- Ketevan BerekashviliBrooklyn$4K
- Steven RudolphBrooklyn$3K
- Sanskriti MishraBrooklyn$1K
- Brandon GiglioBrooklyn$515
- Emma CiafaloniRochester$569K
- Koto IshidaNew York$63K
- Charles ThorntonRochester$40K
- Richard JungBay Shore$38K
- Sammy PishanidarFlushing$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.